# EDGAR Filing Document

**Accession Number:** 0002007702
**File Stem:** 0001213900-25-109034
**Filing Date:** 2025-11
**Character Count:** 96062
**Document Hash:** d915fab830124bd523acdbd68f1e915b
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001213900-25-109034.hdr.sgml**: 20251112

**ACCESSION NUMBER**: 0001213900-25-109034

**CONFORMED SUBMISSION TYPE**: SCHEDULE 13D

**PUBLIC DOCUMENT COUNT**: 3

**FILED AS OF DATE**: 20251112

**DATE AS OF CHANGE**: 20251112

**SUBJECT COMPANY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Hong Kong Pharma Digital Technology Holdings Ltd
- **CENTRAL INDEX KEY:** 0002007702
- **STANDARD INDUSTRIAL CLASSIFICATION:** WHOLESALE-DRUGS PROPRIETARIES & DRUGGISTS' SUNDRIES [5122]
- **ORGANIZATION NAME:** 07 Trade & Services
- **EIN:** 000000000
- **STATE OF INCORPORATION:** E9
- **FISCAL YEAR END:** 0331

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13D
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 005-95062
- **FILM NUMBER:** 251471284

**BUSINESS ADDRESS:**
- **ADDRESS IS A NON US LOCATION:** YES
- **STREET 1:** ROOM B1, 5/F. WELL TOWN IND. BUILDING
- **STREET 2:** 13 KO FAI ROAD, YAU TONG
- **CITY:** KOWLOON
- **PROVINCE COUNTRY:** K3
- **BUSINESS PHONE:** (852) 26189289

**MAIL ADDRESS:**
- **ADDRESS IS A NON US LOCATION:** YES
- **STREET 1:** ROOM B1, 5/F. WELL TOWN IND. BUILDING
- **STREET 2:** 13 KO FAI ROAD, YAU TONG
- **CITY:** KOWLOON
- **PROVINCE COUNTRY:** K3
**FILED BY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Wang Liying
- **CENTRAL INDEX KEY:** 0002096212

**ORGANIZATION NAME:**

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13D

**MAIL ADDRESS:**
- **ADDRESS IS A NON US LOCATION:** YES
- **STREET 1:** ROOM B1 5F WELL TOWN INDUSTRIAL BUIDLING
- **STREET 2:** 13 KO FAI ROAD, YAU TONG
- **CITY:** KOWLOON
- **PROVINCE COUNTRY:** K3
- **ZIP:** 00000

## Exhibit 99.1

**Exhibit 99.1**

**JOINT FILING AGREEMENT**

In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, the undersigned agree to the joint filing on behalf of each of them of a Statement on Schedule 13D (including any and all amendments thereto) with respect to the par value $0.001 per share, of Hong Kong Pharma Digital Technology Holdings Limited, and further agree that this Joint Filing Agreement shall be included as an exhibit to such joint filings.

The undersigned further agree that each party hereto is responsible for the timely filing of such Statement on Schedule 13D and any amendments thereto, and for the accuracy and completeness of the information concerning such party contained therein; provided, however, that no party is responsible for the accuracy or completeness of the information concerning any other party, unless such party knows or has reason to believe that such information is inaccurate

This Joint Filing Agreement may be signed in counterparts with the same effect as if the signature on each counterpart were upon the same instrument.

IN WITNESS WHEREOF, the undersigned have executed this Joint Filing Agreement as of October 13, 2025.

---

| | |
|:---|:---|
| **TUTU Business Services Limited** | **TUTU Business Services Limited** |
| By. | /s/ Liying Wang |
| Name: | Liying Wang |
| Title: | Director |

---

---

| |
|:---|
| /s/ Liying Wang |
| Liying Wang |

---

## Exhibit 99.2

**Exhibit 99.2**

**<u>CERTAIN IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THE EXHIBIT BECAUSE IT IS BOTH (i) NOT MATERIAL, AND (ii) WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED. REDACTED MATERIAL IS MARKED WITH A [\*].</u>**

**<u>Dated the 9th day of July 2025</u>**

**Lap Sun Wong**

and

**Fame Overseas Supply Chain Limited**

and

**Profit Seeker Limited**

and

**HongKong Profit Fields Group Limited**

and

**Pacific Health Century International Group Limited**

(as Sellers)

and

**TUTU Business Services Limited**

(as Purchaser)

**SHARE PURCHASE AGREEMENT**

**CONTENTS**

---

| | | |
|:---|:---|:---|
| **Clause** | **Heading** | **Page** |
| 1. | INTERPRETATION | 2 |
| 2. | SALE AND PURCHASE OF SALE SHARES | 8 |
| 3. | PURCHASE PRICE | 8 |
| 4. | CONDITIONS | 10 |
| 5. | COMPLETION | 12 |
| 6. | POST-COMPLETION UNDERTAKINGS | 13 |
| 7. | REPRESENTATIONS AND WARRANTIES OF THE SELLERS | 14 |
| 8. | REPRESENTATIONS AND WARRANTIES OF THE PURCHASER | 17 |
| 9. | COSTS AND STAMP DUTY | 17 |
| 10. | INDEPENDENT LEGAL ADVICE | 18 |
| 11. | GENERAL | 18 |
| 12. | NOTICES | 19 |
| 13. | THIRD PARTY RIGHTS | 20 |
| 14. | GOVERNING LAW AND JURISDICTION | 21 |
| 15. | TERMINATION | 21 |
| 16. | INDEMNIFICATION | 21 |
| SCHEDULE I | SCHEDULE I | Schedule I-1 |
| SCHEDULE II | SCHEDULE II | Schedule II-1 |
| SCHEDULE III | SCHEDULE III | Schedule III-1 |

---

**THIS AGREEMENT** is made on this 9<sup>th</sup> day of July 2025

**BY AND BETWEEN**

(1) Lap
 Sun Wong (also known as Wong Lap Sun), holder of HKID No. [\*], of Room A, 52/F, Residence
 Oasis, 15 Pui Shing Road, Hang Hau, New Territories, Hong Kong ()"**Mr. Wong** ");

(2) Fame
 Overseas Supply Chain Limited, a company incorporated in the British Virgin Islands with
 registered office at Vistra Corporate Services Center, Wickhams Cay II, Road Town, Tortola
 VG1110, British Virgin Islands ()"**Fame Overseas** ");

(3) Profit
 Seeker Limited, a company incorporated in the British Virgin Islands with registered office
 at Vistra Corporate Services Center, Wickhams Cay II, Road Town, Tortola VG1110, British
 Virgin Islands ()"**Profit Seeker** ");

(4) HongKong
 Profit Fields Group Limited, a company incorporated in Hong Kong with its registered address
 at Building A7, Guangsha Road, Fuyong Town, Bao'an District, Shenzhen City, Guangdong Province,
 China ()"**HK Profit Fields** ");

(5) Pacific
 Health Century International Group Limited, a company incorporated in the British Virgin
 Islands with registered office at 3rd Floor, Omar Hodge Building, Wickhams Cay I, Road Town,
 Tortola, British Virgin Islands ()"**Pacific Health**" and together with Mr.
 Wong, Fame Overseas, Profit Seeker and HK Profit Field, the "**Sellers** "
 and each a "**Seller** "); and

(6) TUTU
 Business Services Limited, a company incorporated in the British Virgin Islands, with its
 registered address at Intershore Chambers, Road Town, Tortola, British Virgin Islands (the
 "**Purchaser** ").

The Sellers and the Purchaser shall hereinafter be collectively referred to as the "**Parties**" and individually as a "**Party**".

**WHEREAS**

(A) Hong
 Kong Pharma Digital Technology Holdings Limited, an exempted company incorporated in the
 Cayman Islands (the "**Company** "), whose shares are listed on Nasdaq. As
 of the date of this Agreement, the Company has an aggregate of 11,000,000 ordinary shares,
 par value $0.001 per share, in issue and outstanding. Further particulars of the Company
 are set out in Schedule I.

(B) As
 of the date of this Agreement, the Sellers are the registered holders of shares in the Company,
 with Fame Overseas holding 4,448,520 ordinary shares, representing approximately 40.44% of
 the total issued and outstanding shares of the Company, Profit Seeker holding 190,020 ordinary
 shares, representing approximately 1.73% of the total issued and outstanding shares of the
 Company, Mr. Wong holding 1,606,421 ordinary shares, representing approximately 14.60% of
 the total issued and outstanding shares of the Company, HK Profit Field holding 470,242 ordinary
 shares, representing approximately 4.27% of the total issued and outstanding shares of the
 Company, and Pacific Health holding 617,850 ordinary shares, representing approximately 5.62%
 of the total issued and outstanding shares of the Company of the total issued and outstanding
 shares of the Company.

(C) The
 Sellers have agreed to sell, and the Purchaser has agreed to purchase, an aggregate of 7,150,000
 ordinary shares, representing approximately 65% of the total issued and outstanding shares
 of the Company (the "**Sale Shares**") upon the terms and subject to the conditions
 set forth in this Agreement.

(D) The
 Parties entered into a letter of intent dated May 15, 2025 (the "**LOI** "),
 pursuant to which the Purchaser paid an initial deposit of HK$[\*] as part payment of
 the Purchase Price, which is being held in escrow as of the date of this Agreement.

**NOW, THEREFORE, IN CONSIDERATION** of the mutual covenants contained in this Agreement, and for other good and valuable consideration the receipt and adequacy of which are hereby acknowledged, the Sellers and the Purchaser agree as follows:

**1.** **INTERPRETATION** 

1.1 In
 this Agreement (including the Recitals and the Schedules), the following expressions have
 the following meanings unless the context requires otherwise:

---

| | |
|:---|:---|
| **"Affiliate"** | means, with respect to any Person, any other Person that directly or indirectly, through one or more intermediaries, controls, is controlled by, or is under common control with, such first Person. For purposes of this definition, "control" as applied to any Person means the possession, directly or indirectly, of the power to direct or cause the direction of the management and policies of that Person, whether through the ownership of voting securities, by contract, or otherwise; |
| **"Agreement"** | means this agreement, and all schedules hereto; |
| **"Applicable Laws"** | means any constitutions, enactments, ordinances, regulations, orders, notices, judgments, common law, treaties and any other legislations or laws of any relevant jurisdictions; |
| **"Board"** | means the board of directors of the Company from time to time; |

---

---

| | |
|:---|:---|
| **"Business Day"** | means a day other than a Saturday, Sunday or public or statutory holiday in Hong Kong and any day on which a tropical cyclone warning No. 8 or above is hoisted or remains hoisted between 9:00 a.m. and 12:00 noon and is not lowered at or before 12:00 noon or on which a "black" rainstorm warning signal is hoisted or remains in effect between 9:00 a.m. and 12:00 noon and is not discontinued at or before 12:00 noon) on which licenced banks in Hong Kong are generally open for business in Hong Kong throughout their normal business hours; |
| **"Claim"** | means, whether or not it is judicial in nature, any assessment, notice, demand, order or other document issued or action taken from which it appears that any person (including corporate) is liable or is sought to be made liable for any payment or obligation or to be deprived of any rights which would, but for the Claim, have been available; |
| "**Companies Ordinance"** | means the Companies Ordinance (Cap. 622 of the Laws of Hong Kong), as amended, supplemented and otherwise modified from time to time; |
| "**Completion"** | has the meaning given to it in Clause 5.1 |
| "**Completion Date"** | has the meaning given to it in Clause 5.1 |
| "Completion Payment" | means the payment described in Clause 3.2(c); |
| **"Conditions"** | has the meaning given to it in Clause 4.1 |
| **"Disclosed"** | in respect of the Sellers' Warranties, disclosed in a full, fair and specific manner in this Agreement, the Published Documents, with sufficient details in all material respects for a reasonable purchaser to make an informed and accurate assessment of the nature, scope and impact of the matters disclosed; |
| **"Encumbrance"** | means a mortgage, Claim, charge, pledge, lien, hypothecation, guarantee, right of set-off, trust, assignment, right of first refusal, right of pre-emption, option, restriction or other encumbrance or any legal or equitable third party right or interest including any security interest of any kind or any type of preferential arrangement (or any like agreement or arrangement creating any of the same or having similar effect) that restricts transfer or other exercise of any attributes of ownership but excluding any restriction arising under US securities laws (including, for the avoidance of doubt, Rule 144 under the Securities Act); |

---

---

| | |
|:---|:---|
| **"Escrow Agent"** | means CFN Lawyers, who shall act in accordance with the terms of the escrow agreement to be entered into between the Parties and the Escrow Agent on or before the date of this Agreement (the **"Escrow Agreement"**); |
| "**Escrowed Documents"** | means the Sellers' duly executed counterparts of (i) the instruments of transfer for all of the Sale Shares, including the transfer instruction forms required by the Company's transfer agent; (ii) the bought and sold notes; (iii) any board or shareholder resolutions (if applicable) approving the sale and purchase of the Sale Shares and the execution of the Transaction Documents by the Sellers and (iv) any documents as agreed in writing between the Sellers and Purchaser explicitly to be included as Escrowed Documents subsequent to the date of this Agreement; |
| **"Exchange Act"** | the United States Securities Exchange Act of 1934, as amended; |
| "**Group**" | means the Company and its Subsidiaries, and the **"Group Company"** shall mean any one of them; |
| "**Hong Kong**" | means the Hong Kong Special Administrative Region of the People's Republic of China; |
| "**HK$**" | means Hong Kong Dollars, the lawful currency of Hong Kong; |
| **"Initial Escrow Amount"** | has the meaning given to it in Clause 3.2; |
| **"LOI"** | has the meaning given to it in the Recitals; |
| **"Long Stop Date"** | has the meaning given to it in Clause 4.2; |

---

---

| | |
|:---|:---|
| **"Material Adverse Effect"** | means any change including without limitation any ongoing, pending or threatened legal proceedings or any Applicable Laws in the region or sector, which, individually or in the aggregate, is reasonably likely to have a material and adverse effect on the financial or trading position, results of operations, profitability, shareholders' equity and business of the Group; |
| "**Nasdaq"** | means The Nasdaq Stock Market LLC; |
| **"ordinary course of business"** | means an action taken by the Company in the ordinary course of business which is consistent with the past practices of the Company; |
| **"Parties"** | the parties to this Agreement; |
| **"Published Documents"** | all documents, including announcements, circulars, annual and interim reports made by or on behalf of the Company published on EDGAR; |
| "**Purchase Price"** | has the meaning ascribed to it under Clause 3.1; |
| **"Purchaser's Warranties"** | means the warranties and representations made by the Purchaser in Clause 8 and "Purchaser's Warranty" means any one of them; |
| **"Sale Shares"** | has the meaning given to it in the Recitals; |
| "**SEC"** | means the United States Securities and Exchange Commission; |
| "**Second Payment**" | means the payment described in Clause 3.2(b); |
| "**Securities Act"** | means the United States Securities Act of 1933, as amended; |
| "**Securities Laws"** | means the securities Laws of United States and the rules and regulations promulgated thereunder (including the Securities Act and the Exchange Act and the rules and regulations thereunder). |
| "**Sellers' Warranties"** | means the warranties and representations made by the Sellers in Clause 7 and Schedule II and "Sellers' Warranty" means any one of them; |

---

---

| | |
|:---|:---|
| "**Share(s)"** | means ordinary share(s) in the share capital of the Company from time to time; |
| "**Shareholder(s)"** | means the holder(s) of Shares in the Company from time to time; |
| **"Subsidiary(ies)"** | means the subsidiaries of the Company (Further particulars of the Subsidiaries are set out in Schedule I); |
| **"Tax" or "Taxation"** | (1) any form of tax whenever created or imposed and whether of Hong Kong or elsewhere, payable to or imposed by any taxation authority and includes, without limitation, profits tax, provisional profits tax, interest tax, salaries tax, property tax, land appreciation tax, taxes on income, estate duty, capital duty, stamp duty, payroll tax and other similar liabilities or contributions and any other taxes, levies, duties, charges, imposts, social security contributions, rates or withholdings similar to, corresponding with, or replacing or replaced by any of the foregoing and including an amount equal to any deprivation of any relief from taxation; and (2) all charges, interests, penalties and fines, incidental or relating to any Taxation falling within (1) above; |
| **"Transaction Documents"** | means this Agreement, the Escrow Agreement, the Escrowed Documents, and all exhibits and schedules thereto and hereto and any ancillary documents required to be delivered at or before the Completion; |
| **"USD" or "US$"** | means United States dollars, the lawful currency of the United States of America. |
| **"%"** | **per cent.** |

---

1.2 In
 this Agreement, unless the context requires otherwise, any reference:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) to
 a Clause or Schedule is a reference to the Clause of or the Schedule to this Agreement;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) to
 this Agreement, any other document, or any provision of this Agreement or that document is
 a reference to this Agreement, that document or that provision as in force for the time being
 or from time to time amended in accordance with the terms of this Agreement or that document;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) to
 a person includes an individual, a body corporate, a partnership, any other unincorporated
 body or association of persons and any state or state agency;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) to
 a time of day is a reference to the time in Hong Kong, unless expressly indicated otherwise;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e) to
 an enactment includes that enactment as it may be amended, replaced or re-enacted at any
 time, whether before or after the date of this Agreement, and any subordinate legislation
 made under it;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f) to
 a "subsidiary" or "holding company" shall have the same meanings
 given to those expressions respectively by sections 13 and 15 of the Companies Ordinance;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g) to
 an "agreement" includes any document or deed, an arrangement and any

other kind of commitment;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(h) to
 a "right" includes a power, a remedy and discretion;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) to
 an "authorisation" includes a licence, filing, registration, exemption and notarisation;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(j) to
 a "Party" or "Parties" is a party or the parties to this Agreement,
 and shall including any successor, permitted assignee and delegate of such Party(ies); and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(k) to
 any document expressed to be "in the agreed form" means a document approved by
 the Parties and, if not entered into contemporaneously with this Agreement, initialled by
 or on behalf of the Parties for the purpose of identification.

1.3 In
 this Agreement, unless the context requires otherwise:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) words
 importing the plural include the singular and vice versa;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) words
 importing a gender include every gender; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) the
 words "other", "including" and "in particular" do not
 limit the generality of any preceding words and are not to be construed as being limited
 to the same class as the preceding words where a wider construction is possible.

1.4 Headings
 are for convenience only and shall not affect the interpretation of this Agreement.

1.5 This
 Agreement includes its Schedules, and any reference to a paragraph is a reference to the
 paragraph of the relevant Schedule.

**2.** **SALE AND PURCHASE OF SALE SHARES** 

2.1 Subject
 to the terms and conditions of this Agreement, each Seller agrees to sell to the Purchaser,
 and the Purchaser agrees to accept and purchase, the following number of Sale Shares free
 from all Encumbrances together with all rights now and hereafter attaching or accruing to
 such Sale Shares, including but not limited to all dividends paid, declared or made in respect
 thereof at any time on or after the Completion Date:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) 1,587,953
 shares (approximately 14.44% of the Company) from Mr. Wong;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) 4,448,520
 shares (approximately 40.44% of the Company) from Fame Overseas;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) 190,020
 shares (approximately 1.73% of the Company) from Profit Seeker;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) 305,657
 shares (approximately 2.78% of the Company) from HK Profit Fields; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e) 617,850
 shares (approximately 5.62% of the Company) from Pacific Health.

2.2 The
 Purchaser shall not be obliged to complete the sale and purchase of any of the Sale Shares
 unless the sale and purchase of all the Sale Shares are completed simultaneously.

2.3 The
 Parties acknowledge that, as of the date of this Agreement, the Sale Shares are "restricted
 securities" as defined in Rule 144 under the Securities Act and subject to resale restrictions
 during the period set forth in Rule 144.

**3.** **PURCHASE PRICE** 

13.1 The
 total purchase price payable by the Purchaser to the Sellers for the Sale Shares shall be
 HK$53,820,000 (equivalent to approximately US$6,900,000 as of the date hereof) (the "**Purchase Price** ").

3.2 Subject
 to and in accordance with this Agreement, the Purchase Price shall be paid by the Purchaser
 to the Sellers as follows:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) HK$[\*]
 (the "**Initial Escrow Amount** "), which has already been paid by the Purchaser
 by banker's cheque issued in favour of the Escrow Agent pursuant to the LOI and shall
 be released to the Sellers upon delivery of the Escrowed Documents in accordance with Clause
 3.5;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) HK$[\*] (the "**Second Payment** "), to be deposited by the Purchaser with
 the Escrow Agent within three (3) Business Days after the date of this Agreement (the **"Second Payment Date"**) and released to the Sellers upon delivery of the Escrowed Documents
 in accordance with Clause 3.5; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) HK$[\*]
 (the "**Completion Payment** "), to be deposited in full with the Escrow Agent
 on within forty-five (45) Business Days after the Escrowed Documents Delivery Date (as defined
 below) or such later date as the Parties may agree in writing (the "**Completion Payment Date)**, of which:-

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) HK$[\*]
 shall be released to the Sellers on the Completion Date; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) HK$[\*]
 (the "**Escrowed Balance**") shall be retained in escrow and released to the
 Sellers upon the Company's filing of its annual report on Form 20-F for the fiscal
 year ending 31 March 2026, unless otherwise agreed in writing by the Parties.

3.3 All
 payments to the Escrow Agent pursuant to this Agreement shall be made by banker's cheque
 issued by a licensed bank in Hong Kong in favour of the Escrow Agent. For the avoidance of
 doubt, the Escrow Agent shall act solely in accordance with the instructions and procedures
 set out in the Escrow Agreement.

3.4 If
 the Purchaser fails to deposit the Second Payment by the Second Payment Date in accordance
 with Clause 3.2(b), the Initial Escrow Amount shall be automatically forfeited and released
 to the Sellers, and this Agreement shall automatically terminate without further action by
 any Party.

3.5 The
 Sellers shall deliver the Escrowed Documents to the Escrow Agent within seven (7) Business
 Days after the Second Payment Date (the "**Escrowed Documents Delivery Date** ").
 Upon such delivery, the Initial Escrow Amount and Second Payment shall become immediately
 non-refundable and shall be released to the Sellers upon the Escrow Agent notifying the Purchaser
 of receipt of the Escrowed Documents, except in the event that Completion does not occur
 due solely to the Sale Shares not being free from Encumbrances in breach of Clause 4.1(b),
 in which case the Sellers shall refund the Initial Escrow Amount and the Second Payment to
 the Purchaser without interest. If the Sellers fail to deliver the Escrowed Documents on
 the Escrowed Documents Delivery Date, the Initial Escrow Amount and the Second Payment shall
 be refunded to the Purchaser without interest, and this Agreement shall automatically terminate
 without further action by any Party. For the avoidance of doubt, the Purchaser may instruct
 the release of the Escrowed Documents only after it has paid the Completion Payment in full
 in accordance with Clause 3.2(c).

3.6 If the Purchaser fails
 to pay the Completion Payment in accordance with Clause 3.2(c) by the Completion Payment Date in accordance with Clause 3.2(c), such
 failure shall constitute a material breach of this Agreement. In such event, the Purchaser shall promptly instruct the Escrow Agent
 in writing to release the Escrowed Documents to the Sellers, and the Sellers shall be entitled to pursue all remedies available under
 this Agreement and applicable law, including claims for the unpaid amount, damages, or specific performance

3.7 Payment
 of the Purchase Price in full in accordance with this Clause 3 shall constitute full and
 final discharge of the Purchaser's payment obligations under this Agreement. For the
 avoidance of doubt, nothing in this Clause shall prejudice any accrued rights or termination
 rights arising prior to such full payment, nor shall it affect any provisions that survive
 termination or Completion.

**4.** **CONDITIONS** 

4.1 The
 Completion of the sale and purchase of the Sale Shares is conditional upon the satisfaction
 or waiver of the following conditions (the "**Conditions** "):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) all
 required regulatory approvals, consents and authorizations (if any) for the transactions
 contemplated by the Transaction Documents having been obtained, and all required filings
 or registrations with any governmental authority having been made;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) the
 Sale Shares are free from all Encumbrances;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) all
 Sellers' Warranties remaining true, accurate and complete in all material respects
 and not misleading in any material respect as at the date of this Agreement and the Completion
 Date by reference to the facts and circumstances subsisting as at the date of this Agreement
 and the Completion Date respectively;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) all
 corporate and other proceedings required to be taken by the Sellers and the Purchaser in
 connection with the transactions contemplated by this Agreement shall have been completed;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e) the
 Purchaser having deposited Second Payment with the Escrow Agent in accordance with Clause
 3.2(b);

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f) the
 Sellers having delivered the Escrowed Documents to the Escrow Agent in accordance with Clause
 3.5; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g) the
 Company's transfer agent's written acknowledgment that the Escrowed Documents
 represent all documents required to be delivered to the transfer agent to effectuate the
 transfer of all the Sale Shares.

4.2 The
 Parties shall use their respective reasonable endeavors to procure the satisfaction of the
 Conditions set out in Clause 4.1 as soon as possible and, in any event, by no later than
 the Completion Payment Date (the "**Long Stop Date** "), or such later date
 as the Parties may agree in writing.

4.3 Any
 Party becoming aware of the satisfaction or potential failure of any Condition shall promptly
 notify the other Parties.

4.4 From
 the date of this Agreement until the earlier of Completion or the termination of this Agreement,
 and except as expressly provided herein or otherwise agreed in writing by the Purchaser (such
 consent not to be unreasonably withheld or delayed), the Sellers shall cause the Company
 to:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) conduct
 its business in the ordinary and usual course consistent with past practice and maintain
 its business organizations and existing relationships and goodwill with customers, suppliers,
 creditors, lessors, employees and business associates in all material respect;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) maintain
 its books of account and records consistent with its past practice in all material respects;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) not
 (i) amend its organizational documents other than amendments which are ministerial in nature;
 (ii) split, combine or reclassify its outstanding share capital; or (iii) repurchase, redeem
 or otherwise acquire any shares of its share capital or any securities convertible into or
 exchangeable or exercisable for any shares of its share capital;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) not
 declare or pay any dividends on or make other distributions in respect of any of its share
 capital;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e) with
 respect to any present or former, director, officer or employee of the Company, not (i) enter
 into any employment or severance agreements or arrangements (except as may be required by
 the terms of any employment agreements existing on the date hereof or by applicable Laws),
 (ii) increase compensation or benefits (except for increases in salary or hourly wage rates,
 in the ordinary course of business consistent with past practice), (iii)
loan or advance any money or other property;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f) not
 issue, sell, or dispose of any shares of, or securities convertible into or exchangeable
 or exercisable for, or options, warrants, calls, commitments or rights of any kind to acquire,
 any shares of its share capital;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g) not
 incur additional indebtedness other than as a result of its ordinary course of business;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(h) not
 sell, assign, lease, license, allow to expire or lapse, encumber or otherwise dispose of
 any material properties and assets, except inventory or de minimis items in its ordinary
 course of business;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) not
 late in making any filings as may be required to be made by the Company in accordance with
 the Securities Laws and the rule of Nasdaq; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(j) not
 suffer any Material Adverse Effect.

**5.** **COMPLETION** 

5.1 Subject
 to the satisfaction or waiver of all the Conditions set out in Clause 4.1, completion of
 the sale and purchase of the Sale Shares ()"**Completion**") shall take place
 at the offices of the Escrow Agent on the Completion Payment Date, or at such other date,
 place or time as the Parties may agree in writing (the "**Completion Date** ").

5.2 At
 Completion, subject to the Purchaser performing its obligations under this Clause 5.2(b)
 and the Sellers performing their obligations under this Clause 5.2(a), each Seller shall
 be deemed to have sold and transferred all of its right, title and interest in and to the
 Sale Shares to the Purchaser:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) the
 Sellers shall deliver or cause to be delivered to the Purchaser:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) such
 other documents as may be reasonably required to effect the transfer of the Sale Shares to
 the Purchaser which were not included in the Escrowed Documents; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) the
 Company's CCC and CIK codes for the filing of submissions with the SEC on the Electronic
 Data Gathering, Analysis, and Retrieval System.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) The
 Purchaser shall:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) pay
 the Completion Payment in accordance with the provisions of Clauses 3.2(c) and 3.3 and, upon
 such payment, promptly instruct the Escrow Agent in writing to release the Escrowed Documents
 to the Purchaser in accordance with the Escrow Agreement; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) deliver
 or cause to be delivered to the Sellers:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) a
 certified copy of the resolutions of the board of directors and shareholders (if required)
 of the Purchaser approving the purchase of the Sale Shares and the execution of the Transaction
 Documents; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) any
 documents necessary for the purpose of effecting the transactions contemplated hereunder.

5.3 Within
 three (3) Business Days following Completion, or such later date as the Parties may agree
 in writing, each of the Sellers shall use its best efforts to procure that the Purchaser
 receives:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) a
 book entry statement of account from the Company's transfer agent for all
the Sale Shares registered in the name of the Purchaser or its nominee; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) a
certified copy of the shareholder's list maintained by transfer agent reflecting the Purchaser as the owner
of the Sale Shares.

5.4 In
 the event that the Sellers or the Purchaser shall fail to do anything required to be done
 by it/him under Clause 5.2 (the **"Defaulting Party** "), without prejudice
 to any other right or remedy available to the Sellers or the Purchaser (as the case may be),
 the Sellers (in case of default by the Purchaser) or the Purchaser (in case of default by
 the Sellers) may by notice to the Defaulting Party elect to:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) upon
 mutual consent by the Sellers and the Purchaser, a further five (5) Business Days after the
 date fixed for Completion;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) proceed
 to Completion so far as practicable but without prejudice to the Sellers' or the Purchaser's
 right (as the case may be) to the extent that the Defaulting Party shall not have complied
 with their obligations hereunder; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) terminate
 this Agreement without any liability on its part, except that termination shall be without
 prejudice to any then accrued rights and obligations of the Parties. For the avoidance of
 doubt, if the Sellers have delivered the Escrowed Documents in accordance with Clause 3.5,
 the Initial Escrow Amount and the Second Payment shall remain non-refundable notwithstanding
 such termination, except in the event of termination under Clause 15.1(b) or 15.1(c).

**6.** **POST-COMPLETION UNDERTAKINGS** 

6.1 Each
 of the Parties undertakes to the others that it will not, at any time after the date of this
 Agreement, divulge or communicate to any person other than to its professional advisers,
 or when required by law or any rule of any relevant stock exchange body, or to its respective
 officers or employees whose province it is to know the same any confidential information
 concerning the business, accounts, finance or contractual arrangements or other dealings,
 transactions or affairs of any of the others or the Group which may be within or may come
 to its knowledge and it shall use its best endeavours to prevent the publication or disclosure
 of any such confidential information concerning such matters.

6.2 No
 public announcement or communication of any kind shall be made in respect of the subject
 matter of this Agreement unless specifically agreed between the Parties or unless an announcement
 is required pursuant to the Applicable Law or the requirements of Nasdaq, SEC or any other
 regulatory body or authority (including the Securities Laws). Any announcement by any Parties
 hereto required to be made pursuant to any relevant law or regulation or the requirements
 of the relevant stock exchange or any other regulatory body or authority
shall be issued only after such prior consultation with the other party as is reasonably practicable in the circumstances.

6.3 Following
 Completion, the Sellers shall, upon reasonable request and at the Purchaser's cost
 and expense, provide such information or execute such documents as may be reasonably necessary
 to assist the Purchaser with the preparation and filing of a resale Registration Statement
 on Form F-1 with the SEC pursuant to the registration requirements under the Securities Act
 covering the Sale Shares, provided that the Sellers shall not be required to provide any
 indemnity, incur any material cost or liability, or make any representations or warranties
 other than as expressly set out in this Agreement.

6.4 For
 a period of 14 months following the Completion, the Sellers shall use their best efforts
 to cooperate with the Purchaser to cause the Company to timely file all reports required
 to be filed pursuant to Section 15 or 13 of the Exchange Act, including compliance with XBRL,
 provided that the Purchaser shall provide all necessary authorisations, approvals, corporate
 actions, and information reasonably requested by the Sellers to perform such cooperation.

**7.** **REPRESENTATIONS AND WARRANTIES OF THE SELLERS** 

7.1 Each
 Seller hereby represents and warrants to the Purchaser (severally and not jointly) that the
 Recitals (to the extent relevant to the Group, Sale Shares and such Sellers), this Clause
 7 and Schedules I and II are true, correct and complete in all material respects and not
 misleading in any material respect as at the date of this Agreement and as at the Completion
 Date.

7.2 Each
 Seller represents and warrants to the Purchaser (severally and not jointly) that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) such
 Seller is the sole legal and beneficial owner of the Sale Shares set opposite its name in
 Clause 2.1 and has full power and authority to sell and transfer such Sale Shares free from
 all Encumbrances;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) such
 Seller has good and valid title to such Sale Shares;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) no
 person has the right (whether exercisable now or in the future and whether contingent or
 not) to call for the transfer, conversion, or issue of any of such Sale Shares under any
 option, agreement, or other arrangement (including conversion rights or rights of pre-emption);

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) the
 Sale Shares sold by such Seller are fully paid and non-assessable and are not subject to
 any option, warrant, pre-emption right, lien, charge, pledge, restriction or other Encumbrance
 (other than the resale restrictions disclosed in Clause 2.3 or otherwise disclosed in this
 Agreement); and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e) the
 execution and delivery of this Agreement by such Seller and the performance of its obligations hereunder will not result in any
 material breach of, or constitute a material default under, any agreement, order, law or obligation binding on such Seller or its
 Sale Shares.

7.3 If,
 at any time prior to Completion, it is discovered that any of the Sale Shares:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) are
 not legally and beneficially owned by the relevant Seller; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) are
subject to any Encumbrance in breach of Clause 7.2; then, subject to Clauses 2.2, 3.5 and 15.1, the Purchaser may:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) terminate
 this Agreement, and the Initial Escrow Amount and Second Payment shall be refunded to the
 Purchaser without interest; and/or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) require
 the relevant Seller to indemnify the Purchaser for direct and reasonably foreseeable losses
 actually suffered provided that such indemnity shall not exceed the portion of the Purchase
 Price already received by the relevant Seller.

7.4 Each
 Seller acknowledges that the Purchaser is entering into this Agreement in reliance
upon the Sellers' Warranties.

7.5 Each
 of the Sellers' Warranties shall be construed as a separate and independent warranty
 and shall not be limited or restricted by reference to or inference from the terms of any
 other warranty or any other term of this Agreement.

7.6 After
 the date of this Agreement:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) if
 any Seller becomes aware that any warranty given as at the date of this Agreement is untrue,
 inaccurate or misleading in any material respect; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) if
 any Seller becomes aware of any matter or circumstances which has arisen and is reasonably
 likely to render the Sellers' Warranties untrue, inaccurate or misleading in any material
 respect (as if such Sellers' Warranties were repeated on Completion),

such Seller shall as soon as reasonably practicable thereafter notify the Purchaser in writing.

7.7 The
 Sellers' Warranties shall be deemed to be repeated as at Completion by reference
to the facts and circumstances existing at that time.

7.8 Where
 any Sellers' Warranty is qualified by the expression "to the Sellers' reasonable
 knowledge, information and belief," it shall be deemed to have been qualified by the
 knowledge of such Seller after having made reasonable due and careful inquiry with the directors
 of the Company and the Subsidiaries and any other person of whom it would be reasonable to
 make such inquiry. Such Sellers'
Warranty shall be qualified in the manner stated only to the extent that the relevant Seller can establish that, prior to giving the
relevant Sellers' Warranty, it has made such inquiry and has used its reasonable endeavours to ensure that all information given
in, referred to, or reflected in, that Sellers' Warranty is true and accurate.

7.9 The
Purchaser shall have the right to Claim against the relevant Seller for breach of the Sellers' Warranties after Completion, provided
that the facts, matters or circumstances giving rise to such breach existed on or before the Completion Date.

7.10 The
 Purchaser shall not assign any representations, Sellers' Warranties, undertakings,
 rights nor the right to make Claims under this Agreement to any person, save and except to
 any holding company or subsidiaries of the Purchaser, without the prior written consent of
 the Sellers.

7.11 Each
 Seller's Warranties are qualified by reference to those matters Disclosed. The Sellers
 will not be liable to the Purchaser and the Group Companies in respect of the Sellers'
 Warranties to the extent the relevant matters are Disclosed.

7.12 The
 Company has filed all reports required to be filed by it under the Securities Act and the
 Exchange Act, including pursuant to Section 13(a) or 15(d) of the Exchange Act, on a timely
 basis. As of their respective dates, to the knowledge of the Sellers, the SEC Reports complied
 in all material respects with the requirements of the Securities Act and the Exchange Act
 and the rules and regulations of the SEC promulgated thereunder, and none of the SEC Reports,
 when filed, contained any untrue statement of a material fact or omitted to state a material
 fact required to be stated therein or necessary in order to make the statements therein,
 in light of the circumstances under which they were made, not misleading. The financial statements
 of the Company included in the SEC Reports complied in all material respects with applicable
 accounting requirements and the rules and regulations of the SEC with respect thereto as
 in effect at the time of filing. To the knowledge of the Sellers, there are no unresolved
 comments of the SEC that are required to be disclosed in the SEC Reports. The Sellers have
 provided to the Purchaser copies of all correspondence with the SEC or any state regulatory
 authority. To the knowledge of the Sellers, none of the Company, the Sellers or any of their
 Affiliates is or has been subject to any investigation or proceeding with the SEC, Nasdaq
 or any state regulatory authority.

7.13 Neither
 such Seller nor any of its Affiliates nor to the knowledge of each Seller, any person acting
 on its behalf has conducted or will conduct any general solicitation (as that term is used
 in Rule 502 of Regulation D) or general advertising with respect to any of the Sale Shares,
 or made any offers or sales of any security or solicited any offers to buy any security under
 any circumstances that would require registration of the Sale Shares under the Securities
 Act.

7.14 Save
 as Disclosed, the Company is not a party to or bound by any agreement or understanding granting
 registration or anti-dilution rights to any person with respect to any of its equity or debt
 securities; no person has a right to purchase or acquire or receive any equity or debt security
 of the Company.

**8.** **REPRESENTATIONS AND WARRANTIES OF THE PURCHASER** 

8.1 The
 Purchaser represents and warrants to the Sellers that the Recitals (to the extent relevant
 to the Purchaser), this Clause 8, and each of the Purchaser's Warranties as set out
 in Schedule III are true, correct and complete in all material respects and not misleading
 in any material respect as at the date hereof.

8.2 The
 Purchaser accepts and acknowledges that the Sellers are entering into this Agreement
in reliance upon the Purchaser's Warranties.

8.3 Each
 of the Purchaser's Warranties shall be construed as a separate and independent warranty
 and shall not be limited or restricted by reference to or inference from the terms of any
 other Purchaser's Warranty or any other term of this Agreement.

8.4 After
 the date of this Agreement:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) if
 the Purchaser becomes aware that any Purchaser's Warranty given as at the date of this
 Agreement is untrue, inaccurate or misleading in any material respect; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) if
 the Purchaser becomes aware of any matter or circumstances which has arisen which is reasonably
 likely to render any of the Purchaser's Warranties untrue, inaccurate or misleading
 in any material respect (as if the Purchaser's Warranties were repeated on Completion),
 the Purchaser shall as soon as reasonably practicable thereafter notify the Sellers in writing.

8.5 The
 Purchaser's Warranties shall be deemed to be repeated as at the Completion by reference
 to the facts and circumstances existing at that time.

**9.** **COSTS AND STAMP DUTY** 

9.1 The
 Sellers and the Purchaser shall bear his/her/its own legal and professional fees, costs and
 expenses incurred in connection with the negotiation, preparation, execution and implementation
 of this Agreement and all documents relating to or in connection with Completion.

9.2 All
 stamp duty payable (if any) in respect of the sale and purchase of the Sale Shares
shall be borne equally by the Sellers on the one part and the Purchaser on the other part.

**10.** **INDEPENDENT LEGAL ADVICE** 

10.1 Each
 of the Parties hereby acknowledges that it **/** he has been afforded the opportunity to
 obtain independent legal advice and confirms by the execution and delivery of this Agreement
 that they have either done so or waived their right to do so in connection with the entering
 into of this Agreement.

**11.** **GENERAL** 

11.1 This
 Agreement shall be binding on and shall enure to the benefit of each Party's successors and
 assigns, but no party may assign any of its rights or obligations hereunder without the prior
 written consent of the other Parties.

11.2 Time
 shall be of the essence of this Agreement.

11.3 The
 failure to exercise, or any delay in exercising, a right or remedy provided by this Agreement
 or by any Applicable Laws shall not impair or constitute a waiver of such right or remedy
 or an impairment of or a waiver of any other right or remedy. No waiver by any party of any
 condition, or the breach of any term, covenant, representation or warranty contained in this
 Agreement, whether by conduct or otherwise, in any one or more instances shall be deemed
 to be or construed as a further or continuing waiver of any such condition or breach or a
 waiver of any other term, covenant, representation or warranty of this Agreement.

11.4 This
 Agreement may be signed in any number of counterparts, each of which shall be binding on
 the Party who shall have executed it and which together shall constitute but one agreement.

11.5 This
 Agreement sets forth the entire agreement and understanding between the Parties in relation
 to the Company and the subject matter of this Agreement and supersedes all previous agreements,
 letters of intent, correspondence, understandings, agreements and undertakings (if any) between
 the Parties with respect to the subject matter hereof, whether written or oral.

11.6 All
 provisions of this Agreement shall so far as they are capable of being performed or observed
 continue in full force and effect notwithstanding Completion except in respect of those matters
 then already performed.

11.7 The
 invalidity, illegality or unenforceability of any provision of this Agreement shall not affect
 or impair the continuation in force of the other provisions of this Agreement.

11.8 Except
 to the extent required by the relevant Applicable Laws, no Party shall (and shall procure
 that none of its directors, employees, independent contractors or subsidiaries shall) at
 any time disclose to any person (other than professional advisers who are subject to obligations
 of confidentiality) the terms of this Agreement or any trade secret or other confidential
 information relating to the Company or the Parties, or make any use of such information other
 than to the extent necessary for the purpose of exercising or performing its rights and obligations
 under this Agreement.

11.9 The Sellers and Purchaser further assure that, at the request of and at the costs
of the Purchaser, it shall (and shall procure any relevant third party to) do and execute or procure to be done and executed all such
further acts, deeds, documents and things as may be necessary to give full effect to the terms and intent of this Agreement.

11.10 The Parties agree that this Agreement shall be deemed to have been severally and
jointly drafted by them, unless otherwise expressly provided herein, and that the provisions of this Agreement therefore shall not be
construed against a Party or Parties on the ground that such Party or Parties drafted or was more responsible for the drafting of any
such provision(s). The Parties further agree that they have each carefully read the terms and conditions of this Agreement, that they
know and understand the contents and effect of this Agreement and that the legal effect of this Agreement has been fully explained to
its satisfaction by counsel of its own choosing.

11.11 This Agreement may be amended, modified, superseded or cancelled, and any of the
terms, covenants, representations, warranties or conditions hereof may be waived, only by a written instrument executed by the Parties
hereto.

11.12 If any term, provision, covenant or restriction of this Agreement is held by a
court of competent jurisdiction or other authority to be invalid, void or unenforceable, the remainder of the terms, provisions, covenants
and restrictions of this Agreement shall remain in full force and effect and shall in no way be affected, impaired or invalidated so long
as the economic or legal substance of the transactions contemplated hereby is not affected in any manner materially adverse to any party.
Upon such determination, the Parties shall negotiate in good faith to modify this Agreement so as to effect the original intent of the
Parties as closely as possible in an acceptable manner in order that the transactions contemplated hereby be consummated as originally
contemplated to the fullest extent possible.

**12.** **NOTICES** 

12.1 Any notice, demand or other communication required or permitted to be given under
this Agreement shall be in writing and shall be delivered personally, sent by prepaid registered post, or sent by email to the address
or email address of the relevant Party set out below (or such other address or email address as the relevant Party may specify by notice
in writing to the other Party):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) If to Mr. Wong:

Address: Room A, 52/F, Residence Oasis, 15 Pui Shing Road, Hang Hau,

New Territories, Hong Kong

Email: [\*]

Attention: <u>Lap Sun Wong</u>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) If to Fame Overseas:

Address: Vistra Corporate Services Center, Wickhams Cay II, Road Town,

Tortola VG1110, British Virgin Islands

Email: [\*]

Attention: <u>Lap Sun Wong</u>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) If to Profit Seeker:

Address: Vistra Corporate Services Center, Wickhams Cay II, Road Town,

Tortola VG1110, British Virgin Islands

Email: [\*]

Attention: <u>Lap Sun Wong</u>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) If to HK Profit Fields:

Address: Building A7, Guangsha Road, Fuyong Town,

Bao'an District, Shenzhen City, Guangdong Province, China

Email: [\*]

Attention: <u>Daliang Yu</u>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e) If to Pacific Health:

Address: 3rd Floor, Omar Hodge Building, Wickhams Cay 1, Road Town,

Tortola, British Virgin Islands

Email: [\*]

Attention: <u>Dongkun Jin</u>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f) If to the Purchaser:

Address: Intershore Chambers, Road Town, Tortola, British Virgin Islands

Email: [\*]

Attention: Liying Wang

12.2 Any notice, demand or other communication shall be deemed to have been served:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) If delivered personally, at the time of delivery;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) If sent by prepaid registered post, 48 hours after posting; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) If sent by email, at the time of transmission (provided that the sender does not
receive an automated message indicating that the email has not been delivered).

**13.** **THIRD PARTY RIGHTS** 

A person who is not a party to this Agreement has no right under the Contracts (Rights of Third Parties) Ordinance (Chapter 623 of the Laws of Hong Kong) to enforce or to enjoy the benefit of any term of this Agreement.

**14.** **GOVERNING LAW AND JURISDICTION** 

14.1 This Agreement shall be governed by and construed in accordance with the laws
of Hong Kong, and the Parties hereby submit to the non-exclusive jurisdiction of the courts of Hong Kong in respect of all matters arising
in connection with this Agreement.

15. TERMINATION

15.1 This Agreement may be terminated:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) by the Sellers in accordance with Clauses 3.4, 3.6, or 5.4;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) by the Purchaser in accordance with Clauses 2.2, 3.5, 5.4 or 7.3;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) if any of the Conditions set out in Clause 4.1 have not been satisfied or waived
by the Long Stop Date (or such later date as may be agreed in writing), unless otherwise expressly provided herein; provided that a Party
shall not be entitled to terminate this Agreement pursuant to this Clause 15.1(c) if the failure of Completion to occur on or prior to
such date has been caused by its own material breach of this Agreement. For the avoidance of doubt, any refunds or forfeitures upon termination
shall remain governed by Clause 3; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) by mutual written agreement of all the Parties.

15.2 Upon termination of this Agreement:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) any obligations of the Parties under this Agreement shall cease, except as expressly
provided herein; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) any rights or obligations accrued prior to termination (including rights to claim
for breach) shall survive.

15.3 Termination of this Agreement shall not affect any clause which is expressed or
intended to survive termination, or any rights or remedies accrued up to the date of termination.

16. INDEMNIFICATION

16.1 <u>Indemnification by Sellers</u>. Each Seller (severally and not jointly) shall
indemnify and hold harmless the Purchaser and its Affiliates, representatives, and their respective successors and assigns from and against
any and all direct and reasonably foreseeable damages, losses, liabilities, taxes, costs and expenses (including reasonable attorney's
fees and costs) (collectively, "**Losses**") arising out of or resulting directly from (a) any material breach by such
Seller of its representations and warranties under this Agreement; or (b) any material breach by such Seller
of its covenants or obligations expressly stated to survive Completion. The maximum aggregate liability of each Seller pursuant to this
Clause 16.1 shall not exceed the portion of the Purchase Price actually received by such Seller.

16.2 <u>Indemnification by Purchaser</u>. Purchaser shall indemnify and hold harmless
the Sellers and Sellers' Affiliates, representatives and their respective successors and assigns from and against any and all Losses
arising out of or resulting directly from (a) any material breach by the Purchaser of its representations and warranties under this Agreement;
or (b) any material breach by the Purchaser of its covenants or obligations expressly stated to survive Completion. The maximum aggregate
liability of the Purchaser pursuant to this Clause 16.2 shall not exceed the sum of the Purchase Price paid by the Purchaser.

16.3 <u>Survival</u>. No claim may be made or no proceeding may be instituted seeking
indemnification pursuant to the Clause 16.1 or the Clause 16.2 unless written notice describing the Claim in reasonable detail (in light
of the circumstances then known to the party seeking indemnification, the "**Indemnified Party**") is delivered to the
party against whom indemnity is sought (the "**Indemnifying Party**") within the following periods: (i) in the case of
any claim for breach of a representation or warranty, within fourteen (14) months after the Completion Date; (ii) in the case of any claim
for non-performance or breach of a covenant or agreement, at any time in accordance with its terms (unless the relevant covenant expressly
provides a shorter survival period). For the avoidance of doubt, if a notice of claim is delivered within the applicable time period,
the relevant representation, warranty, covenant, or agreement shall survive until such claim is finally resolved.

(*the remainder of the page is intentionally left blank*)

**IN WITNESS WHEREOF** the Parties have duly executed this Agreement the day and year first above written.

---

| | | | |
|:---|:---|:---|:---|
| **<u>SELLERS</u>** | **<u>SELLERS</u>** | | |
| **For and on behalf of Fame Overseas Supply Chain Limited** | **For and on behalf of Fame Overseas Supply Chain Limited** | **For and on behalf of HongKong Profit Fields Group Limited** | **For and on behalf of HongKong Profit Fields Group Limited** |
| /s/ Wong Lap Sun | /s/ Wong Lap Sun | /s/ Yu Daliang | /s/ Yu Daliang |
| Name: | Wong Lap Sun | Name : | Yu Daliang |
| Title: | Director | Title: | Director |
| **For and on behalf of Profit Seeker Limited** | **For and on behalf of Profit Seeker Limited** | **For and on behalf of Pacific Health Century International Group Limited** | **For and on behalf of Pacific Health Century International Group Limited** |
| /s/ Wong Lap Sun | /s/ Wong Lap Sun | /s/ Jin Dongkun | /s/ Jin Dongkun |
| Name: | Wong Lap Sun | Name: | Jin Dongkun |
| Title: | Director | Title: | Director |
| **Wong Lap Sun** | **Wong Lap Sun** | | |
| /s/ Wong Lap Sun | /s/ Wong Lap Sun | | |
| Name: | Wong Lap Sun | | |
| **<u>PURCHASER</u>** | **<u>PURCHASER</u>** | | |
| **For and on behalf of <br> TUTU Business Services Limited** | **For and on behalf of <br> TUTU Business Services Limited** | | |
| /s/ Wang Liying | /s/ Wang Liying | | |
| Name: | Wang Liying | | |
| Title: | Director | | |

---

**<u>SCHEDULE I</u>**

**Particulars of the Company**

1. Registered Office : 4<sup>th</sup> Floor, Harbour Place, 103 South Church Street, P.O. Box 10240, Grand Cayman KY1- 1002, Cayman
ISlands

2. Place of Incorporation : Cayman Islands

3. Date of Incorporation : August 17, 2023

4. Company Number : 402778

5. Director(s) : Wong Lap Sun <br>
Zhang Zhifang <br>
Chan Kam Leung<br>
 Lai King Yin<br>
 Zou Yue

6. Authorised Share Capital : US$100,000 divided into 100,000,000 ordinary shares of par value of US$0.001 each

7. Total number of Outstanding Shares : 11,000,000 Ordinary Shares

8. Subsidiaries : Joint Cross Boarder Logistics Company Limited V-Alliance Technology Supplies Limited

Schedule I-1

**Part B**

**Particulars of the Subsidiaries**

---

| | |
|:---|:---|
| Name | Joint Cross Boarder Logistics Company Limited |
| Place of incorporation | Hong Kong |
| Date of incorporation | July 18, 2017 |
| Authorised share capital | HK$2,000,000 divided into 2,000,000 ordinary shares of par value of HK$1.00 each |
| Issued share capital | 2,000,000 Ordinary Shares |
| Shareholder(s) | Hong Kong Pharma Digital Technology Holdings Limited (100%) |
| Director(s) | Wong Lap Sun <br> Zhang Zhifang |
| Registered office | Room B1, 5/F., Well Town Industrial Building, 13 Ko Fai Road, Yau Tong, Kowloon |
| Principal activity | Providing comprehensive supply chain solutions for pharmaceutical cross-border e-commerce |

---

Schedule I-2

---

| | |
|:---|:---|
| Name | V-Alliance Technology Supplies Limited |
| Place of incorporation | Hong Kong |
| Date of incorporation | September 1, 2016 |
| Authorised share capital | HK$3,980,001 divided into 10,000,002 ordinary shares of par value of HK$0.398 each |
| Issued share capital | 10,000,002 Ordinary Shares |
| Shareholder(s) | Hong Kong Pharma Digital Technology Holdings Limited (100%) |
| Director(s) | Wong Lap Sun |
| Registered office | Room B1, 5/F., Well Town Industrial Building, 13 Ko Fai Road, Yau Tong, Kowloon |
| Principal activity | OTC pharmaceutical cross-border procurement and distribution |

---

Schedule I-3

**<u>SCHEDULE II</u>**

**SELLERS' WARRANTIES**

The Purchaser acknowledges that HongKong Profit Fields Group Limited and Pacific Health Century International Group Limited (the "**Minority Sellers**") are minority shareholders with no executive or managerial involvement in the Group. The Minority Sellers give only the warranties in paragraphs 1.1–2.4 and 3.1–3.3 (relating to title to shares and authority to enter into this Agreement). All other warranties in this Schedule II are given only by Mr. Wong, Fame Overseas Supply Chain Limited, and Profit Seeker International Group Limited.

1. General

1.1 The information in this Agreement (including the Recitals and as set out in the
Schedules), except those relating to the Purchaser, are true, complete and accurate in all material respects and not misleading in any
material respect whether by omission or otherwise.

1.2 To each of the Sellers' reasonable knowledge, information and belief, all
information supplied or Disclosed by or on behalf of the Sellers, members of the Group and any directors of members of the Group to the
Purchaser or the legal and other professional advisers to the Purchaser for the purpose of this Agreement is true and accurate in all
material respects and not misleading in any material respect.

1.3 To each of the Sellers' reasonable knowledge, information and belief, there
is no information about any event or circumstance giving rise to a Material Adverse Effect that has not been Disclosed.

2. Sale Shares

2.1 Each Seller is the sole legal, record and beneficial owner of the Sale Shares set
opposite its name in Clause 2.1 and has full power and authority to sell and transfer such Sale Shares free from all Encumbrances, together
with all rights attaching or accruing to such Sale Shares.

2.2 The Sale Shares are fully paid and non-assessable, and are not subject to any option,
warrant, pre-emption right, lien, charge, pledge, restriction or other Encumbrance (other than the resale restrictions disclosed in Clause
2.3 or otherwise disclosed in this Agreement).

2.3 The Sale Shares will represent approximately 65% of the total issued and outstanding
shares of the Company upon Completion.

2.4 Such Seller does not own any options, derivatives, warrants or securities which
are convertible or exchangeable into any Shares, and has not entered into any agreement for the issue of such options, derivatives, warrants
or securities which are convertible or exchangeable into any Shares.

Schedule II-1

3. Authority and Capacity of Sellers

3.1 Each Seller has requisite right, power authority and capacity to enter into and
perform this Agreement, to consummate the transactions contemplated hereby and to perform his obligations under this Agreement.

3.2 This Agreement, when executed, will constitute legal, valid, binding and enforceable
obligations on the Sellers in accordance with its terms.

3.3 The execution and performance of this Agreement by each Seller will not violate or
breach any Applicable Laws binding on or in relation to such Seller.

4. The Group

4.1 All corporate or other documents, accounts, returns and resolutions required by
all Applicable Laws to be filed or registered in respect of the Group with the relevant authorities have been duly filed or registered
in all material respects.

4.2 The statutory books and minute books of the Group have been properly written up in
all material respects.

4.3 Each of the Company and the Subsidiaries has (i) complied with its constitutional
documents in all material respects, and (ii) obtained all material licences, consents and other permissions and regulatory or third party
approvals required for the business activities and transactions of the Group.

4.4 There is no material violation of, or breach with respect to, any ordinance, statute,
regulation, order, decree or judgement of any court or any government agency of any jurisdiction by the Group.

4.5 Information and belief, no events or omissions have occurred whereby the constitution,
subsistence, registration or corporate status of the members of the Group has been or is reasonably likely to be materially and adversely
affected.

5. Liabilities and Accounting Records

5.1 Save for those relating to the ordinary course of business of the Group, there
will be no outstanding guarantee, indemnity, surety, security or comfort (whether or not legally binding) given by the Group in respect
of the obligations or liabilities of any third parties upon Completion.

Schedule II-2

5.2 The Group will upon Completion have sufficient assets to discharge its outstanding
liabilities as at Completion which arise from events or activities occurring on or before the Completion Date (including without limitation
Tax liabilities) in all material respects.

5.3 The accounting and other books and records of the Group are in its possession, up-to-date
and have been properly written up, maintained and accurately present and reflect in accordance with generally accepted accounting principles
and practices all the transactions entered into by each Group member or to which a Group member has been a party in all material respects.

6. Taxation

6.1 The Group has within the requisite time limits duly made all material returns,
given all notices, and supplied all other information required under all Applicable Laws to be supplied to any competent fiscal authority
in Hong Kong and the United States.

6.2 Each of the Company and the Subsidiaries is not in and not subject to any material
dispute with competent tax authorities in Hong Kong at the date hereof.

6.3 The Group has or will have paid or accounted for all material Taxation (if any)
due to be paid or accounted for by it on or before the Completion Date.

7. Litigation

7.1 The Group is not a party to any material proceedings and no material proceedings
are threatened or pending either by or against the Group.

7.2 There are no facts or circumstances which are reasonably likely to result in any
material proceedings being bought by or against the Group or against any person for whose acts or defaults the Group may be vicariously
liable.

7.3 There are no material unfulfilled or unsatisfied judgments, court orders or tribunal
or arbitral awards outstanding against the Group.

7.4 There are no investigations, disciplinary proceedings or other circumstances reasonably
likely to lead to any material Claim or legal action, proceeding, suit, litigation, prosecution, official investigation, enquiry or arbitration.

8. Contracts and Commitments

8.1 The Company or the Subsidiaries is not in material breach of any deed, agreement
or undertaking to which it is a party.

8.2 No party with whom the Company or the Subsidiaries has entered into any material
agreement or arrangement is in default thereunder.

Schedule II-3

8.3 The Group has not given any power of attorney or any other authority (express, implied
or ostensible) which is still outstanding or effective to any person to enter into any contract or commitment or do anything on its behalf
that would have a Material Adverse Effect on the Group.

8.4 No offer, tender or the like which is capable of being converted into material obligation
of the Group by an acceptance or other act of some other person is outstanding.

8.5 The Group has not lent any money or provided any credit or advance in the sum of more
than 100% of the Purchase Price to any person as at the date of this Agreement.

9. Solvency

9.1 No order has been made or petition presented or resolution passed for the winding
up of the Group, nor has any distress, execution or other process been levied against the Group.

9.2 No steps have been taken for the appointment of an administrator or receiver of
any part of the property, assets, undertakings or business of the Group.

9.3 None of the Company and the Subsidiaries is insolvent or unable to pay its debts as
they fall due.

10. Employees

10.1 The Group will not upon Completion be a party to and will not have any material
agreement, arrangement or scheme, except those Disclosed and/or according to any Applicable Laws, and/or any transactions contemplated
under this Agreement.

10.2 Each of the Company and the Subsidiaries has not breached any material statutory
requirements in relation to employment of its staff.

10.3 No circumstances have arisen under which the Subsidiaries are required to pay, or
is reasonably likely to be required to pay, material damages in relation to the dismissal of or to reinstate or re-engage any former employee
upon Completion.

10.4 There are no share options or share incentive or similar schemes for any officers
or employees of the Company or the Subsidiaries.

10.5 There is no term of employment for any employee or engagement of any consultant
of the Company or the Subsidiaries which provides that a change of direct or indirect shareholding of the Company or the Subsidiaries
as amounting to a breach of contract, entitling him to any material payment or benefit or entitling him to treat himself as dismissed
or released from any obligation.

Schedule II-4

11. Insurance

11.1 The Group has effected and maintains valid policies of insurance in an amount and
to the extent that it is required to maintain under all applicable legislations and laws and necessary for the conduct of the business
of the Group, including without limitation, insurance policies covering Claims arising from workplace safety in all material respects.

11.2 All material premiums due in respect of such policies of insurance have been paid.

11.3 There are no circumstances which would or is reasonably likely to entitle the Group
to make a material Claim under any of the policies or which would or might be required under any of the policies to be notified to the
insurers.

12. Intellectual Property

12.1 The definition in this paragraph applies in this agreement:

**Intellectual Property Rights:** all intellectual property rights owned by the Group, including patents, utility models, rights to inventions, copyright and neighbouring and related rights, moral rights, trade marks and service marks, business names and domain names, rights in get-up and trade dress, goodwill and the right to sue for passing off or unfair competition, rights in designs, rights in computer software, database rights, rights to use, and protect the confidentiality of, confidential information (including know-how and trade secrets), and all other intellectual property rights, in each case whether registered or unregistered and including all applications and rights to apply for and be granted, renewals or extensions of, and rights to claim priority from, such rights and all similar or equivalent rights or forms of protection which subsist as at the date of this Agreement in any part of the world.

12.2 The Company or the Subsidiary(ies) is the sole legal and beneficial owner of (or
applicant for) the Intellectual Property Rights free from all Encumbrances.

12.3 The Company or the Subsidiaries has not used any Intellectual Property Right in
a manner that infringes the Intellectual Property Rights of any third party and there are no outstanding material claims against the Company
or the Subsidiaries for such infringement.

12.4 The Company or the Subsidiaries does not require any other material Intellectual Property
Rights other than those currently owned in order to carry on the business as it is conducted at the date of this Agreement.

12.5 The Intellectual Property Rights are valid, subsisting and enforceable and nothing
has been done, or not been done, as a result of which any of them has ceased or might cease to be valid, subsisting or enforceable in
all material respect.

Schedule II-5

12.6 Nothing is due to be done the omission of which would jeopardise the maintenance
or prosecution of any of the Intellectual Property Rights owned or used by the Company or the Subsidiaries which are registered or the
subject of an application for registration.

12.7 There has been no material infringement by any third party of any of the Intellectual
Property Rights, nor any third party breach of confidence, passing off or actionable act of unfair competition in relation to the business
and assets of the Company or the Subsidiaries.

13. Properties

13.1 Each relevant Group Company has observed and performed in all material respects
all material covenants, restrictions, stipulations and other Encumbrances under the leases entered into by such Group Company (the **"Leases"**).

13.2 In relation to the Leases, all material lease sums have been paid as and when they
became due.

13.3 The transactions contemplated herein do not constitute a ground for termination
of the Leases.

14. Assets

14.1 The latest audited consolidated financial statements of the Group for the year
ended 31 March 2024 show the true and accurate value of the net tangible asset value of the Group in all material respects and the Sellers
are not aware of any event materially affecting the value.

14.2 The Group holds all its assets as the legal and beneficial owner thereof free from
any Encumbrance on the Completion Date.

14.3 None of the assets, undertaking or goodwill of the Group is subject to an Encumbrance
or any agreement or commitment to create an Encumbrance, and to each of the Sellers' reasonable knowledge, information and belief,
no person has claimed to be entitled to create such an Encumbrance.

14.4 The assets owned by the Group comprise all the assets necessary for the continuation
of the business of the Group as it is carried on at the date of this Agreement.

15. Licence, permit and authorization

15.1 The business of the Group in Hong Kong is in all in compliance with all material
Applicable Laws in material respects.

Schedule II-6

15.2 The Group possesses all material certificates issued by, and has made all material
declarations and filings with, the appropriate governmental or regulatory authorities that are necessary for its conduct of business.
To each of the Sellers' reasonable knowledge, information and belief, neither the Company nor any Subsidiary has received written
notice of any proceeding relating to revocation or modification of any such material certificate or has any reason to believe that such
certificate will not be renewed in the ordinary course, except where the failure to obtain any such renewal would not, individually or
in the aggregate, have a Material Adverse Effect.

16. Financial Matters

16.1 There has not been:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) any material damage, destruction, or loss, whether covered
by insurance or not, materially adversely affecting the properties, assets or business of the Group;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) any material sale or transfer by the Company or the Subsidiaries
of any material tangible or intangible asset other than in the ordinary course of business, any mortgage or pledge or the creation of
any security interest, lien, or encumbrance on any such asset, or any lease of property;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) any material transaction not in the ordinary course of business
of the Group;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) lapse of any material patent, utility models, design, trademark,
trade name, service mark, copyright, or licence or any application with respect to the foregoing by the Group;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e) the making of any material loan, advance, indemnity or guarantee
by the Group to or for the benefit of any person except the creation of accounts receivable in the ordinary course of business; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f) an agreement to do any of the foregoing.

16.2 The accounting books and records of the Group have been maintained in accordance
with the applicable accounting principles adopted in the jurisdictions where the Group's business is conducted and comply with the
relevant statutory provisions of such jurisdictions and have been properly written up and properly reflect all the material transactions
to which the Group has been a party and there are at the date hereof no material inaccuracies or discrepancies of any kind contained or
reflected in the said books and records.

16.3 Save as in the ordinary course of business and/or any commitment in relation to
this Agreement, the Group does not have any material capital commitment or is engaged in any scheme or project requiring the expenditure
of capital of an aggregate amount more than 100% of the Purchase Price.

16.4 The Group does not have any material obligations or liabilities other than those which have arisen in the ordinary course of its business
or by operation of law or Disclosed in the financial statements.

Schedule II-7

16.5 The Group has not as at the date hereof and will not, as at Completion, have outstanding
any significant borrowing, indebtedness, mortgage, charge, debenture, guarantee or contingent obligation.

16.6 All material dividends or distributions declared, made or paid by the Company or
the Subsidiaries have been declared, made or paid in accordance with its articles of association (or equivalent documents) and the applicable
statutory provisions.

17. Material adverse changes

17.1 Since 31 March 2024, there has been no material adverse change in the Group's financial
position or trading position or its level of turnover or its turnover and, the Sellers are not aware of any event, fact or matter that
has occurred or is reasonably likely to which would give rise to any such change.

18. Miscellaneous

18.1 No material consents or approvals from third parties or government or regulatory
authorities are required for the performance of the obligations under this Agreement that have not already been obtained as of the relevant
Completion Date.

18.2 The performance of this Agreement will not cause or be a ground for termination
for any material agreement (including without limitation banking facilities agreement, lease, supply contracts and licensing agreements)
entered into by any of the Group Companies in its ordinary and usual course of business.

Schedule II-8

**<u>SCHEDULE III</u>**

**PURCHASER'S WARRANTIES**

1. The Purchaser is a private company limited by shares and incorporated
and validly existing under the laws of its place of incorporation.

2. The Purchaser is not a "U.S. Person" as defined by Regulation S of the
Securities Act and is not acquiring the Shares for the account or benefit of a U.S. Person.

3. The Purchaser acknowledges that the Purchaser was not in the United States at the
time the offer to purchase the Seller Shares was received from the Seller and that all substantive negotiations and communications between
the Sellers and the Purchaser have occurred outside the United States.

4. The Purchaser has full legal capacity and, if required, has obtained or will obtain
prior to Completion, all authorisations or approvals under the laws of Hong Kong to enter into and exercise his rights and perform his
obligations under this Agreement and other ancillary transaction documents, when executed, will constitute legal, valid, binding and enforceable
obligations on the Purchaser in accordance with its terms.

5. The Purchaser is acquiring the Sale Shares in an offshore transaction as defined
in Regulation S. The offer and sale of the Sale Shares were not made to the Purchaser in the United States, and the Purchaser was outside
the United States at the time the offer was made and at the time the Purchase Agreement was entered into.

6. The Purchaser agrees that the Sale Shares have not been registered under the Securities
Act and may not be offered or sold in the United States absent registration or an applicable exemption from registration under the Securities
Act.

7. The Purchaser acknowledges and agrees that it will not engage in hedging transactions
involving the Sale Shares unless in compliance with the Securities Act.

8. The Purchaser agrees that it will not offer or sell the Sale Shares to any U.S.
Person or in the United States during the applicable distribution compliance period (as defined in Regulation S), except pursuant to an
effective registration statement or a valid exemption from the registration requirements under the Securities Act.

9. The Purchaser acknowledges that the Sale Shares are "restricted securities"
as defined under Rule 144 under the Securities Act and will remain subject to resale restrictions under U.S. securities laws.

10. The Purchaser has taken all necessary action to enter into and perform this Agreement
and to carry out the transactions contemplated hereby.

11. The execution, delivery and performance of this Agreement
by the Purchaser do not and will not result in:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) any violation or breach of any provision of any applicable laws or regulations in Hong Kong;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) a breach of, or constitute a default under, any instrument to which the Purchaser
is a party or by which the Purchaser is bound; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) a violation of any Applicable Laws or any order, judgement or decree of any court
or governmental agency or agreement to which the Purchaser is party or by which the Purchaser is bound.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;12. The Purchaser has and will have sufficient funds to pay the Purchase Price in full
and in the manner as provided in this Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;13. There is no litigation, arbitration or administrative proceedings pending or threatened
against the Purchaser before any court, arbitral body or agency, which might reasonably be expected to have a Material Adverse Effect
on its ability to perform his obligations under this Agreement.

Schedule III-1

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## SCHEDULE 13D

### Under the Securities Exchange Act of 1934

**Hong Kong Pharma Digital Technology Holdings Limited**

*(Name of Issuer)*

**Ordinary Shares, par value $0.001 per share**

*(Title of Class of Securities)*

**G6365B104**

*(CUSIP Number)*

**Liying Wang**<br>Room B1, 5/F, Well Town Ind<br>13 Ko Fai Rd, Yau Tong<br>Kowloon K3 999077<br>852 5394-2145

*(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)*

**10/06/2025**

*(Date of Event Which Requires Filing of this Statement)*

| **CUSIP No.** | **G6365B104** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**Liying Wang** | Name of reporting person<br>**Liying Wang** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**PF** | Source of funds (See Instructions)<br>**PF** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**CHINA** | Citizenship or place of organization<br>**CHINA** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**7150000.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**7150000.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**0.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**7150000.00** | Aggregate amount beneficially owned by each reporting person<br>**7150000.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**65%** | Percent of class represented by amount in Row (11)<br>**65%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**IN** | Type of Reporting Person (See Instructions)<br>**IN** | |

---

| **CUSIP No.** | **G6365B104** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**TUTU Business Services Limited** | Name of reporting person<br>**TUTU Business Services Limited** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**OO** | Source of funds (See Instructions)<br>**OO** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**D8** | Citizenship or place of organization<br>**D8** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**7150000.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**7150000.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**0.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**7150000.00** | Aggregate amount beneficially owned by each reporting person<br>**7150000.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**65%** | Percent of class represented by amount in Row (11)<br>**65%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**CO** | Type of Reporting Person (See Instructions)<br>**CO** | |

---

**Comment for Reporting Person:** (1) TUTU Business Services Limited, a company incorporated in the British Virgin Islands, with its registered address at Intershore Chambers, Road Town, Tortola, British Virgin Islands, holds 7,150,000 ordinary shares, par value $0.001 per share, of Hong Kong Pharma Digital Technology Holdings Limited. Liying Wang is the sole shareholder and director of TUTU Business Services Limited. Consequently, she may be deemed the beneficial owner of the securities held by TUTU Business Services Limited and exercises voting and dispositive power over such securities

(2) Percentage is calculated on the basis of 11,000,000 ordinary shares, par value $0.001 per share, of Hong Kong Pharma Digital Technology Holdings Limited in issue and outstanding as of October 6, 2025.

**Item 1. Security and Issuer**

**(a) Title of Class of Securities:**
Ordinary Shares, par value $0.001 per share

**(b) Name of Issuer:**
Hong Kong Pharma Digital Technology Holdings Limited

**(c) Address of Issuer's Principal Executive Offices:**
Room B1, 5/F, Well Town Ind, 13 Ko Fai Rd, Yau Tong, Kowloon, K3, 999077

This Schedule 13D relates to ordinary shares, par value $0.001 per share, of Hong Kong Pharma Digital Technology Holdings Limited, having the principal executive offices at c/o Room B1, 5/F., Well Town Industrial Building, 13 Ko Fai Road, Yau Tong, Kowloon Hong Kong.

**Item 4. Purpose of Transaction**

Effective September 9, 2025, the board ("Board") of directors of the Company appointed Mr. Zhou Mike Yao as an independent director of the Company and a member of the nomination committee of the Board.

On October 6, 2025, the Board of the Company received and accepted the resignation of Mr. Wong Lap Sun from his position as Chief Executive Officer, the resignation of Mr. Zhifang Zhang from his position as Executive Director, and the resignation of Mr. Kwok Man Bun from his position as Chief Financial Officer effective immediately.  Previously on April 30, 2025, the Board received and accepted the resignation of Ms. Yingying Li from her position as Chief Operating Officer, effective immediately. Effective on October 6, 2025, the Board appointed Mr. Chenyu Liang as Director and Chief Executive Officer, Ms. Shu Liu as Chief Financial Officer and Mr. Zifeng Wang as Chief Strategy Officer of the Company.

The Reporting Persons purchased the Shares based on the Reporting Persons' belief that the Shares, when purchased, represented an attractive investment opportunity. As a result of its ability to vote 65% of all the share capital of the Company, the Reporting Persons have the power to significantly influence the election of directors and all other matters that would require the vote of the outstanding share capital of the Company. Subject to the restrictions on transfer arising under US securities laws (including, for the avoidance of doubt, Rule 144 under the Securities Act), depending upon overall market conditions, other investment opportunities available to the Reporting Persons, and the availability of ordinary shares at prices that would make the purchase or sale of such shares desirable, the Reporting Persons may endeavor to increase or decrease their position in the Company through, among other things, the purchase or sale of ordinary shares on the open market or in private transactions or otherwise, on such terms and at such times as the Reporting Persons may deem advisable.

Additionally, the Reporting Persons may, from time to time, evaluate and consider various strategic alternatives with respect to their investment in the Company. These alternatives may include, but are not limited to, proposing or considering one or more of the following: a merger, consolidation, reorganization, recapitalization, asset acquisition, asset sale, or other business combination involving the Company; a change in the present board of directors or management of the Company; a material change in the present capitalization or dividend policy of the Company; a material change in the Company's business or corporate structure; or any other action otherwise set forth in subparagraphs (a) through (j) of Item 4 of Schedule 13D.

**Item 5. Interest in Securities of the Issuer**

**(a)**
The aggregate number and percentage of the Company's ordinary shares to which this Schedule 13D relates is 7,150,000 ordinary shares held by the Reporting Persons constituting 65% of the Company's outstanding ordinary shares.

**(b)**
The Reporting Persons hold sole power to vote or direct the vote, and sole power to dispose of the Shares. The percentages used herein are calculated based upon 11,000,000 ordinary shares, par value $0.001 per share, of the Company in issue and outstanding as of October 6, 2025.

**(c)**
Other than the transaction described herein there has been no other transactions known to the Reporting Persons concerning the ordinary shares of the Company effected during the past sixty (60) days.

**Item 6. Contracts, Arrangements, Understandings or Relationships With Respect to Securities of the Issuer.**

The Reporting Persons have entered into a Joint Filing Agreement, attached hereto as Exhibit 99.1, pursuant to which they have agreed to file this Schedule 13D jointly in accordance with the provisions of Rule 13d-1(k) of the Act.

The information set forth in Item 3, 4 and 5 of this Schedule 13D is hereby incorporated by reference into this Item 6, as applicable.

Other than the foregoing agreements and arrangements, there are no contracts, arrangements, understandings or relationships (legal or otherwise) among the Reporting Persons and any other person with respect to any securities of the Company, including, but not limited to transfer or voting of any of the securities, finder's fees, joint ventures, loan or option arrangements, puts or calls, guarantees of profits, division of profits or loss, or the giving or withholding of proxies.

### SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** Liying Wang

**Signature:** /s/ Liying Wang

**Name/Title:** Liying Wang

**Date:** 10/13/2025

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** TUTU Business Services Limited

**Signature:** /s/ Liying Wang

**Name/Title:** Liying Wang

**Date:** 10/13/2025